KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Supernus Pharmaceuticals (SUPN) over the last 15 years, with Q3 2025 value amounting to $11.1 million.

  • Supernus Pharmaceuticals' Other Working Capital Changes rose 53571.02% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.1 million, marking a year-over-year increase of 221490.51%. This contributed to the annual value of $19.4 million for FY2024, which is 569401.2% up from last year.
  • As of Q3 2025, Supernus Pharmaceuticals' Other Working Capital Changes stood at $11.1 million, which was up 53571.02% from $2.5 million recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Other Working Capital Changes registered a high of $28.2 million during Q2 2023, and its lowest value of -$20.4 million during Q3 2023.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$766500.0 (2022), whereas its average is $562812.5.
  • Data for Supernus Pharmaceuticals' Other Working Capital Changes shows a peak YoY increase of 360347.83% (in 2023) and a maximum YoY decrease of 155633.12% (in 2023) over the last 5 years.
  • Quarter analysis of 5 years shows Supernus Pharmaceuticals' Other Working Capital Changes stood at -$4.7 million in 2021, then tumbled by 97.87% to -$9.2 million in 2022, then grew by 15.22% to -$7.8 million in 2023, then soared by 238.52% to $10.8 million in 2024, then rose by 3.09% to $11.1 million in 2025.
  • Its Other Working Capital Changes was $11.1 million in Q3 2025, compared to $2.5 million in Q2 2025 and -$7.4 million in Q1 2025.